Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Farazi Paymon | Chief Product Officer | 6 | $0 | $0 | 2023-03-29 |
| Gronniger Tim | Ch. Value-Based Sols. Off | 6 | $0 | $0 | 2023-03-29 |
| Goldberg Arnold | Director | 9 | $0 | $0 | 2023-03-29 |
| Riefberg Vivian E. | Director | 10 | $333.6K | $0 | 2023-03-29 |
| McAnaney Adam | General Counsel and Secretary | 18 | $333.6K | $0 | 2023-03-29 |
| Rothman Marc D | Chief Medical Officer | 15 | $24.0K | $0 | 2023-03-29 |
| Peterson Kyle B. | Director | 4 | $0 | $0 | 2023-03-29 |
| Clayton Taj J. | Director | 13 | $0 | $0 | 2023-03-29 |
| Builder Josh | Chief Technology Officer | 14 | $0 | $0 | 2023-03-29 |
| Pierre David | Chief Operating Officer | 13 | $316.8K | $0 | 2023-03-29 |
| Dixon Heather Brianne | Director | 4 | $0 | $0 | 2023-03-29 |
| Senneff Steve | Pres., Chief Fin. & Admin Off. | 21 | $824.0K | $0 | 2023-03-29 |
| Armbrester Bradford Kyle | Chief Executive Officer | 28 | $431.5K | $0 | 2023-03-29 |
| Holt Matthew S. | Director | 4 | $0 | $0 | 2023-03-29 |
| ORTON LAURENCE MICHAEL | Chief Operating Officer | 10 | $124.8K | $0 | 2023-03-29 |
| Hull Brandon H | Director | 11 | $333.6K | $0 | 2023-03-29 |
| MCNAMARA KEVIN M | Director | 10 | $0 | $0 | 2023-03-29 |
| NOTINI ALBERT A | Director | 4 | $0 | $0 | 2023-03-29 |
| New Mountain Partners V (AIV-C), L.P. | Director, 10% Owner | 1 | $0 | $0 | 2022-05-19 |
| Boumenot Peter | Chief Product Officer | 6 | $0 | $0 | 2022-03-07 |
| Douty Laurel | EVP, Clinic. Ops, Care Srvces | 6 | $240.0K | $0 | 2022-03-07 |
| Pettijohn Sam | Chief Growth Officer | 2 | $0 | $0 | 2021-07-16 |
| Wiggins Stephen F | Director | 11 | $0 | $0 | 2021-04-01 |
| New Mountain Capital, L.L.C. | Director, 10% Owner | 5 | $0 | $0 | 2021-02-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Clayton Taj J. | Director | C Conversion deriv | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 0 | SEC↗ |
| Hull Brandon H | Director | C Conversion deriv | 2023-03-29 | 2023-03-29 | 1,030,500 | — | $0 | 0 | SEC↗ |
| MCNAMARA KEVIN M | Director | C Conversion deriv | 2023-03-29 | 2023-03-29 | 1,260,850 | — | $0 | 0 | SEC↗ |
| Farazi Paymon | Chief Product Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 142,125 | — | $0 | 0 | SEC↗ |
| Gronniger Tim | Ch. Value-Based Sols. Off | D To issuer deriv | 2023-03-29 | 2023-03-29 | 132,138 | — | $0 | 0 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Operating Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 44,400 | — | $0 | 0 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Operating Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 142,370 | — | $0 | 0 | SEC↗ |
| Riefberg Vivian E. | Director | C Conversion deriv | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 0 | SEC↗ |
| Pierre David | Chief Operating Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 317,127 | — | $0 | 0 | SEC↗ |
| Pierre David | Chief Operating Officer | C Conversion deriv | 2023-03-29 | 2023-03-29 | 772,875 | — | $0 | 0 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | D To issuer deriv | 2023-03-29 | 2023-03-29 | 50,000 | — | $0 | 0 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | D To issuer deriv | 2023-03-29 | 2023-03-29 | 213,556 | — | $0 | 0 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | D To issuer deriv | 2023-03-29 | 2023-03-29 | 132,138 | — | $0 | 0 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | C Conversion deriv | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 0 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | D To issuer deriv | 2023-03-29 | 2023-03-29 | 883,932 | — | $0 | 0 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | C Conversion deriv | 2023-03-29 | 2023-03-29 | 506,975 | — | $0 | 0 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | D To issuer deriv | 2023-03-29 | 2023-03-29 | 211,419 | — | $0 | 0 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 105,711 | — | $0 | 0 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 50,000 | — | $0 | 0 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | C Conversion deriv | 2023-03-29 | 2023-03-29 | 120,837 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | C Conversion deriv | 2023-03-29 | 2023-03-29 | 1,043,854 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | C Conversion deriv | 2023-03-29 | 2023-03-29 | 1,260,625 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 634,257 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | C Conversion deriv | 2023-03-29 | 2023-03-29 | 3,686,599 | — | $0 | 0 | SEC↗ |
| Builder Josh | Chief Technology Officer | C Conversion deriv | 2023-03-29 | 2023-03-29 | 145,011 | — | $0 | 0 | SEC↗ |
| Builder Josh | Chief Technology Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 150,000 | — | $0 | 0 | SEC↗ |
| Builder Josh | Chief Technology Officer | D To issuer deriv | 2023-03-29 | 2023-03-29 | 132,138 | — | $0 | 0 | SEC↗ |
| Clayton Taj J. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 35,657 | SEC↗ |
| Clayton Taj J. | Director | C Conversion | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 50,329 | SEC↗ |
| Clayton Taj J. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 0 | SEC↗ |
| Clayton Taj J. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 35,657 | — | $0 | 0 | SEC↗ |
| Hull Brandon H | Director | C Conversion | 2023-03-29 | 2023-03-29 | 1,030,500 | — | $0 | 1,030,500 | SEC↗ |
| Hull Brandon H | Director | D To issuer | 2023-03-29 | 2023-03-29 | 1,030,500 | — | $0 | 0 | SEC↗ |
| Hull Brandon H | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 21,816 | SEC↗ |
| Hull Brandon H | Director | D To issuer | 2023-03-29 | 2023-03-29 | 1,030,500 | — | $0 | 0 | SEC↗ |
| Hull Brandon H | Director | D To issuer | 2023-03-29 | 2023-03-29 | 21,816 | — | $0 | 0 | SEC↗ |
| Holt Matthew S. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 0 | SEC↗ |
| MCNAMARA KEVIN M | Director | D To issuer | 2023-03-29 | 2023-03-29 | 22,588 | — | $0 | 0 | SEC↗ |
| MCNAMARA KEVIN M | Director | C Conversion | 2023-03-29 | 2023-03-29 | 1,260,850 | — | $0 | 1,260,850 | SEC↗ |
| MCNAMARA KEVIN M | Director | D To issuer | 2023-03-29 | 2023-03-29 | 1,260,850 | — | $0 | 0 | SEC↗ |
| MCNAMARA KEVIN M | Director | D To issuer | 2023-03-29 | 2023-03-29 | 1,260,850 | — | $0 | 0 | SEC↗ |
| Farazi Paymon | Chief Product Officer | D To issuer | 2023-03-29 | 2023-03-29 | 237,269 | — | $0 | 0 | SEC↗ |
| Goldberg Arnold | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 18,072 | SEC↗ |
| Goldberg Arnold | Director | D To issuer | 2023-03-29 | 2023-03-29 | 18,072 | — | $0 | 0 | SEC↗ |
| Peterson Kyle B. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 0 | SEC↗ |
| Gronniger Tim | Ch. Value-Based Sols. Off | D To issuer | 2023-03-29 | 2023-03-29 | 188,576 | — | $0 | 135,008 | SEC↗ |
| Gronniger Tim | Ch. Value-Based Sols. Off | D To issuer | 2023-03-29 | 2023-03-29 | 135,008 | — | $0 | 0 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Operating Officer | D To issuer | 2023-03-29 | 2023-03-29 | 24,994 | — | $0 | 7,740 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Operating Officer | D To issuer | 2023-03-29 | 2023-03-29 | 7,740 | — | $0 | 0 | SEC↗ |
| Riefberg Vivian E. | Director | C Conversion | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 60,661 | SEC↗ |
| Riefberg Vivian E. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 45,989 | SEC↗ |
| Riefberg Vivian E. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 0 | SEC↗ |
| Riefberg Vivian E. | Director | D To issuer | 2023-03-29 | 2023-03-29 | 45,989 | — | $0 | 0 | SEC↗ |
| Pierre David | Chief Operating Officer | C Conversion | 2023-03-29 | 2023-03-29 | 772,875 | — | $0 | 972,056 | SEC↗ |
| Pierre David | Chief Operating Officer | D To issuer | 2023-03-29 | 2023-03-29 | 805,938 | — | $0 | 0 | SEC↗ |
| Pierre David | Chief Operating Officer | D To issuer | 2023-03-29 | 2023-03-29 | 772,875 | — | $0 | 0 | SEC↗ |
| Pierre David | Chief Operating Officer | D To issuer | 2023-03-29 | 2023-03-29 | 166,118 | — | $0 | 805,938 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | D To issuer | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 0 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | D To issuer | 2023-03-29 | 2023-03-29 | 69,062 | — | $0 | 0 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | D To issuer | 2023-03-29 | 2023-03-29 | 85,137 | — | $0 | 69,062 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | C Conversion | 2023-03-29 | 2023-03-29 | 24,173 | — | $0 | 154,199 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | D To issuer | 2023-03-29 | 2023-03-29 | 506,975 | — | $0 | 0 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | D To issuer | 2023-03-29 | 2023-03-29 | 139,691 | — | $0 | 669,616 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | C Conversion | 2023-03-29 | 2023-03-29 | 506,975 | — | $0 | 809,307 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | D To issuer | 2023-03-29 | 2023-03-29 | 669,616 | — | $0 | 0 | SEC↗ |
| NOTINI ALBERT A | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 0 | SEC↗ |
| Dixon Heather Brianne | Director | D To issuer | 2023-03-29 | 2023-03-29 | 14,672 | — | $0 | 15,002 | SEC↗ |
| Dixon Heather Brianne | Director | D To issuer | 2023-03-29 | 2023-03-29 | 15,002 | — | $0 | 0 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | D To issuer | 2023-03-29 | 2023-03-29 | 127,910 | — | $0 | 0 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | D To issuer | 2023-03-29 | 2023-03-29 | 120,837 | — | $0 | 0 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | D To issuer | 2023-03-29 | 2023-03-29 | 61,163 | — | $0 | 127,910 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | C Conversion | 2023-03-29 | 2023-03-29 | 120,837 | — | $0 | 189,073 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 348,097 | — | $0 | 3,720,068 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | C Conversion | 2023-03-29 | 2023-03-29 | 1,260,625 | — | $0 | 1,260,625 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | C Conversion | 2023-03-29 | 2023-03-29 | 1,043,854 | — | $0 | 1,043,854 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | C Conversion | 2023-03-29 | 2023-03-29 | 3,686,599 | — | $0 | 4,068,165 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 3,686,599 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 1,043,854 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 1,260,625 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 3,720,068 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 1,043,854 | — | $0 | 0 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2023-03-29 | 2023-03-29 | 1,260,625 | — | $0 | 0 | SEC↗ |
| Builder Josh | Chief Technology Officer | C Conversion | 2023-03-29 | 2023-03-29 | 145,011 | — | $0 | 271,455 | SEC↗ |
| Builder Josh | Chief Technology Officer | D To issuer | 2023-03-29 | 2023-03-29 | 119,871 | — | $0 | 151,584 | SEC↗ |
| Builder Josh | Chief Technology Officer | D To issuer | 2023-03-29 | 2023-03-29 | 145,011 | — | $0 | 0 | SEC↗ |
| Builder Josh | Chief Technology Officer | D To issuer | 2023-03-29 | 2023-03-29 | 151,584 | — | $0 | 0 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | F Tax w/h | 2023-03-07 | 2023-03-09 | 5,660 | $28.37 | $160.6K | 302,332 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Accounting Officer | F Tax w/h | 2023-03-07 | 2023-03-09 | 1,160 | $28.37 | $32.9K | 32,734 | SEC↗ |
| Gronniger Tim | Ch. Value-Based Sols. Off | F Tax w/h | 2023-03-07 | 2023-03-09 | 3,821 | $28.37 | $108.4K | 323,584 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | F Tax w/h | 2023-03-07 | 2023-03-09 | 3,750 | $28.37 | $106.4K | 130,026 | SEC↗ |
| Pierre David | Chief Operating Officer | F Tax w/h | 2023-03-07 | 2023-03-09 | 6,564 | $28.37 | $186.2K | 199,181 | SEC↗ |
| Builder Josh | Chief Technology Officer | F Tax w/h | 2023-03-07 | 2023-03-09 | 4,438 | $28.37 | $125.9K | 126,444 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | F Tax w/h | 2023-03-07 | 2023-03-09 | 2,736 | $28.37 | $77.6K | 68,236 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | F Tax w/h | 2023-03-07 | 2023-03-09 | 6,369 | $28.37 | $180.7K | 381,566 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | A Award | 2023-02-27 | 2023-03-01 | 86,836 | — | $0 | 307,992 | SEC↗ |
| Pierre David | Chief Operating Officer | A Award | 2023-02-27 | 2023-03-01 | 86,836 | — | $0 | 205,745 | SEC↗ |
| Builder Josh | Chief Technology Officer | A Award | 2023-02-27 | 2023-03-01 | 86,836 | — | $0 | 130,882 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | A Award | 2023-02-27 | 2023-03-01 | 34,735 | — | $0 | 70,972 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Accounting Officer | A Award | 2023-02-27 | 2023-03-01 | 13,894 | — | $0 | 33,894 | SEC↗ |
| Farazi Paymon | Chief Product Officer | A Award | 2023-02-27 | 2023-03-01 | 86,836 | — | $0 | 237,269 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award | 2023-02-27 | 2023-03-01 | 295,242 | — | $0 | 387,935 | SEC↗ |
| Gronniger Tim | Ch. Value-Based Sols. Off | A Award | 2023-02-27 | 2023-03-01 | 86,836 | — | $0 | 327,405 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award | 2023-02-27 | 2023-03-01 | 52,102 | — | $0 | 133,776 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2022-12-30 | 2023-01-03 | 633 | — | $0 | 32,744 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2022-12-30 | 2023-01-03 | 633 | — | $0 | 26,156 | SEC↗ |
| Farazi Paymon | Chief Product Officer | A Award | 2022-11-03 | 2022-11-04 | 103,058 | — | $0 | 150,433 | SEC↗ |
| Gronniger Tim | Ch. Value-Based Sols. Off | A Award | 2022-11-03 | 2022-11-04 | 68,705 | — | $0 | 240,569 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2022-09-30 | 2022-10-03 | 622 | — | $0 | 32,111 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2022-09-30 | 2022-10-03 | 622 | — | $0 | 25,523 | SEC↗ |
| Farazi Paymon | Chief Product Officer | A Award deriv | 2022-08-03 | 2022-08-05 | 142,125 | — | $0 | 142,125 | SEC↗ |
| Farazi Paymon | Chief Product Officer | A Award | 2022-08-03 | 2022-08-05 | 47,375 | — | $0 | 47,375 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2022-06-30 | 2022-07-05 | 1,314 | — | $0 | 31,489 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2022-06-30 | 2022-07-05 | 1,314 | — | $0 | 24,901 | SEC↗ |
| Riefberg Vivian E. | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 36,488 | SEC↗ |
| MCNAMARA KEVIN M | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 22,588 | SEC↗ |
| Hull Brandon H | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 36,488 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 23,587 | SEC↗ |
| NOTINI ALBERT A | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 14,672 | SEC↗ |
| Peterson Kyle B. | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 14,672 | SEC↗ |
| Holt Matthew S. | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 14,672 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 30,175 | SEC↗ |
| Dixon Heather Brianne | Director | A Award | 2022-05-19 | 2022-05-23 | 14,672 | — | $0 | 29,674 | SEC↗ |
| New Mountain Partners V (AIV-C | Director, 10% Owner | A Award | 2022-05-19 | 2022-05-23 | 44,016 | — | $0 | 67,764 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | P Buy | 2022-05-09 | 2022-05-09 | 8,320 | $11.77 | $97.9K | 92,693 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | P Buy | 2022-05-09 | 2022-05-09 | 2,500 | $11.75 | $29.4K | 217,587 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | P Buy | 2022-05-06 | 2022-05-06 | 10,000 | $12.55 | $125.5K | 215,087 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2022-03-31 | 2022-04-04 | 999 | — | $0 | 8,915 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2022-03-31 | 2022-04-04 | 999 | — | $0 | 15,503 | SEC↗ |
| Douty Laurel | EVP, Clinic. Ops, Care Srvce | A Award deriv | 2022-03-07 | 2022-03-09 | 132,138 | — | $0 | 132,138 | SEC↗ |
| Pierre David | Chief Operating Officer | A Award deriv | 2022-03-07 | 2022-03-09 | 317,127 | — | $0 | 317,127 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Accounting Officer | A Award deriv | 2022-03-07 | 2022-03-09 | 44,400 | — | $0 | 44,400 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award deriv | 2022-03-07 | 2022-03-09 | 132,138 | — | $0 | 132,138 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | A Award deriv | 2022-03-07 | 2022-03-09 | 105,711 | — | $0 | 105,711 | SEC↗ |
| Builder Josh | Chief Technology Officer | A Award deriv | 2022-03-07 | 2022-03-09 | 132,138 | — | $0 | 132,138 | SEC↗ |
| Boumenot Peter | Chief Product Officer | A Award deriv | 2022-03-07 | 2022-03-09 | 105,711 | — | $0 | 105,711 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award deriv | 2022-03-07 | 2022-03-09 | 634,257 | — | $0 | 634,257 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | A Award deriv | 2022-03-07 | 2022-03-09 | 211,419 | — | $0 | 211,419 | SEC↗ |
| Douty Laurel | EVP, Clinic. Ops, Care Srvce | A Award | 2022-03-07 | 2022-03-09 | 44,046 | — | $0 | 54,046 | SEC↗ |
| Pierre David | Chief Operating Officer | A Award | 2022-03-07 | 2022-03-09 | 105,709 | — | $0 | 118,909 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Accounting Officer | A Award | 2022-03-07 | 2022-03-09 | 14,800 | — | $0 | 20,000 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award | 2022-03-07 | 2022-03-09 | 44,046 | — | $0 | 81,674 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | A Award | 2022-03-07 | 2022-03-09 | 35,237 | — | $0 | 36,237 | SEC↗ |
| Builder Josh | Chief Technology Officer | A Award | 2022-03-07 | 2022-03-09 | 44,046 | — | $0 | 44,046 | SEC↗ |
| Boumenot Peter | Chief Product Officer | A Award | 2022-03-07 | 2022-03-09 | 35,237 | — | $0 | 35,237 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award | 2022-03-07 | 2022-03-09 | 70,473 | — | $0 | 84,373 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | A Award | 2022-03-07 | 2022-03-09 | 70,473 | — | $0 | 205,087 | SEC↗ |
| Holt Matthew S. | Director | J Other | 2022-02-16 | 2022-02-18 | 7,916 | — | $0 | 0 | SEC↗ |
| NOTINI ALBERT A | Director | J Other | 2022-02-16 | 2022-02-18 | 7,916 | — | $0 | 0 | SEC↗ |
| Peterson Kyle B. | Director | J Other | 2022-02-16 | 2022-02-18 | 7,916 | — | $0 | 0 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | P Buy | 2021-11-22 | 2021-11-23 | 2,500 | $13.27 | $33.2K | 134,614 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | P Buy | 2021-11-17 | 2021-11-18 | 10,000 | $14.92 | $149.2K | 132,114 | SEC↗ |
| Senneff Steve | Pres. Chief Fin. & Admin. Of | P Buy | 2021-11-16 | 2021-11-18 | 10,000 | $15.32 | $153.2K | 122,114 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2021-08-25 | 2021-08-27 | 14,662 | — | $0 | 14,662 | SEC↗ |
| Goldberg Arnold | Director | A Award | 2021-08-25 | 2021-09-17 | 14,504 | — | $0 | 14,504 | SEC↗ |
| Pettijohn Sam | Chief Growth Officer | A Award deriv | 2021-07-16 | 2021-07-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Pettijohn Sam | Chief Growth Officer | A Award | 2021-07-16 | 2021-07-20 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Dixon Heather Brianne | Director | A Award | 2021-05-13 | 2021-05-17 | 15,002 | — | $0 | 15,002 | SEC↗ |
| Wiggins Stephen F | Director | M Exercise deriv | 2021-04-01 | 2021-04-02 | 5,561 | — | $0 | 16,684 | SEC↗ |
| Wiggins Stephen F | Director | M Exercise | 2021-04-01 | 2021-04-02 | 5,561 | $2.28 | $12.7K | 7,889,487 | SEC↗ |
| Wiggins Stephen F | Director | M Exercise deriv | 2021-03-31 | 2021-04-02 | 111,583 | — | $0 | 0 | SEC↗ |
| Wiggins Stephen F | Director | M Exercise deriv | 2021-03-31 | 2021-04-02 | 66,736 | — | $0 | 22,245 | SEC↗ |
| Wiggins Stephen F | Director | M Exercise | 2021-03-31 | 2021-04-02 | 111,583 | $1.74 | $194.2K | 7,817,190 | SEC↗ |
| Wiggins Stephen F | Director | M Exercise | 2021-03-31 | 2021-04-02 | 66,736 | $2.28 | $152.2K | 7,883,926 | SEC↗ |
| Douty Laurel | EVP, Clinic. Ops, Care Srvce | P Buy | 2021-02-16 | 2022-03-09 | 10,000 | $24.00 | $240.0K | 10,000 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| Holt Matthew S. | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| NOTINI ALBERT A | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| MCNAMARA KEVIN M | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| Hull Brandon H | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| Hull Brandon H | Director | P Buy | 2021-02-16 | 2021-02-17 | 13,900 | $24.00 | $333.6K | 21,816 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Accounting Officer | P Buy | 2021-02-16 | 2021-02-17 | 5,200 | $24.00 | $124.8K | 5,200 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | P Buy | 2021-02-16 | 2021-02-17 | 13,900 | $24.00 | $333.6K | 37,628 | SEC↗ |
| Peterson Kyle B. | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| Pierre David | Chief Operating Officer | P Buy | 2021-02-16 | 2021-02-17 | 13,200 | $24.00 | $316.8K | 13,200 | SEC↗ |
| Riefberg Vivian E. | Director | P Buy | 2021-02-16 | 2021-02-17 | 13,900 | $24.00 | $333.6K | 21,816 | SEC↗ |
| Riefberg Vivian E. | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | P Buy | 2021-02-16 | 2021-02-17 | 1,000 | $24.00 | $24.0K | 1,000 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | P Buy | 2021-02-16 | 2021-02-17 | 13,900 | $24.00 | $333.6K | 112,114 | SEC↗ |
| Wiggins Stephen F | Director | A Award | 2021-02-16 | 2021-02-17 | 7,916 | — | $0 | 7,916 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | P Buy | 2021-02-16 | 2021-02-17 | 13,900 | $24.00 | $333.6K | 13,900 | SEC↗ |
| New Mountain Capital, L.L.C. | Director, 10% Owner | A Award | 2021-02-16 | 2021-02-17 | 23,748 | — | $0 | 23,748 | SEC↗ |
| Boumenot Peter | Chief Product Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 161,865 | — | $0 | 161,865 | SEC↗ |
| Boumenot Peter | Chief Product Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 24,173 | — | $0 | 24,173 | SEC↗ |
| Clayton Taj J. | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 24,173 | — | $0 | 24,173 | SEC↗ |
| Builder Josh | Chief Technology Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 145,011 | — | $0 | 145,011 | SEC↗ |
| Douty Laurel | EVP, Clinic. Ops, Care Srvce | A Award deriv | 2021-02-12 | 2021-02-17 | 145,042 | — | $0 | 145,042 | SEC↗ |
| MCNAMARA KEVIN M | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 230,350 | — | $0 | 230,350 | SEC↗ |
| MCNAMARA KEVIN M | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 1,030,500 | — | $0 | 1,030,500 | SEC↗ |
| Hull Brandon H | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 1,030,500 | — | $0 | 1,030,500 | SEC↗ |
| ORTON LAURENCE MICHAEL | Chief Accounting Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 142,370 | — | $0 | 142,370 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award deriv | 2021-02-12 | 2021-02-17 | 24,173 | — | $0 | 24,173 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award deriv | 2021-02-12 | 2021-02-17 | 213,556 | — | $0 | 213,556 | SEC↗ |
| Pierre David | Chief Operating Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 772,875 | — | $0 | 772,875 | SEC↗ |
| Riefberg Vivian E. | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 24,173 | — | $0 | 24,173 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 120,837 | — | $0 | 120,837 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | A Award deriv | 2021-02-12 | 2021-02-17 | 506,975 | — | $0 | 506,975 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | A Award deriv | 2021-02-12 | 2021-02-17 | 883,932 | — | $0 | 883,932 | SEC↗ |
| Wiggins Stephen F | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 111,583 | — | $0 | 111,583 | SEC↗ |
| Wiggins Stephen F | Director | A Award deriv | 2021-02-12 | 2021-02-17 | 88,981 | — | $0 | 88,981 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 1,260,625 | — | $0 | 1,260,625 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 1,043,854 | — | $0 | 1,043,854 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 1,476,659 | — | $0 | 1,476,659 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award deriv | 2021-02-12 | 2021-02-17 | 2,209,940 | — | $0 | 2,209,940 | SEC↗ |
| New Mountain Capital, L.L.C. | Director, 10% Owner | A Award deriv | 2021-02-12 | 2021-02-17 | 42,905,113 | — | $0 | 42,905,113 | SEC↗ |
| Boumenot Peter | Chief Product Officer | A Award | 2021-02-12 | 2021-02-17 | 186,038 | $0.01 | $1.9K | 186,038 | SEC↗ |
| Clayton Taj J. | Director | A Award | 2021-02-12 | 2021-02-17 | 24,173 | $0.01 | $242 | 24,173 | SEC↗ |
| Builder Josh | Chief Technology Officer | A Award | 2021-02-12 | 2021-02-17 | 145,011 | $0.01 | $1.5K | 145,011 | SEC↗ |
| Douty Laurel | EVP, Clinic. Ops, Care Srvce | A Award | 2021-02-12 | 2021-02-17 | 145,042 | $0.01 | $1.5K | 145,042 | SEC↗ |
| MCNAMARA KEVIN M | Director | A Award | 2021-02-12 | 2021-02-17 | 1,260,850 | $0.01 | $12.6K | 1,260,850 | SEC↗ |
| Hull Brandon H | Director | A Award | 2021-02-12 | 2021-02-17 | 1,030,500 | $0.01 | $10.3K | 1,030,500 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award | 2021-02-12 | 2021-02-17 | 24,173 | $0.01 | $242 | 24,173 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award | 2021-02-12 | 2021-02-17 | 23,728 | — | $0 | 23,728 | SEC↗ |
| Pierre David | Chief Operating Officer | A Award | 2021-02-12 | 2021-02-17 | 772,875 | $0.01 | $7.7K | 772,875 | SEC↗ |
| Riefberg Vivian E. | Director | A Award | 2021-02-12 | 2021-02-17 | 24,173 | $0.01 | $242 | 24,173 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | A Award | 2021-02-12 | 2021-02-17 | 120,837 | $0.01 | $1.2K | 120,837 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | A Award | 2021-02-12 | 2021-02-17 | 98,214 | — | $0 | 98,214 | SEC↗ |
| Senneff Steve | Pres., Chief Fin. & Admin Of | A Award | 2021-02-12 | 2021-02-17 | 506,975 | $0.01 | $5.1K | 506,975 | SEC↗ |
| Wiggins Stephen F | Director | A Award | 2021-02-12 | 2021-02-17 | 4,048 | — | $0 | 4,048 | SEC↗ |
| Wiggins Stephen F | Director | A Award | 2021-02-12 | 2021-02-17 | 7,697,691 | — | $0 | 7,697,691 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award | 2021-02-12 | 2021-02-17 | 1,260,625 | $0.01 | $12.6K | 1,260,625 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award | 2021-02-12 | 2021-02-17 | 1,043,854 | $0.01 | $10.4K | 1,043,854 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | A Award | 2021-02-12 | 2021-02-17 | 3,686,599 | $0.01 | $36.9K | 3,686,599 | SEC↗ |
| Armbrester Bradford Kyle | Chief Executive Officer | D To issuer | 2021-02-12 | 2021-02-17 | 100 | $1.00 | $100 | 0 | SEC↗ |
| New Mountain Capital, L.L.C. | Director, 10% Owner | A Award | 2021-02-12 | 2021-02-17 | 48,330,828 | — | $0 | 48,330,828 | SEC↗ |
| New Mountain Capital, L.L.C. | Director, 10% Owner | A Award | 2021-02-12 | 2021-02-17 | 42,905,113 | $0.01 | $429.1K | 42,905,113 | SEC↗ |
| New Mountain Capital, L.L.C. | Director, 10% Owner | A Award | 2021-02-12 | 2021-02-17 | 48,378,865 | — | $0 | 48,378,865 | SEC↗ |
| Boumenot Peter | Chief Product Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Builder Josh | Chief Technology Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Douty Laurel | EVP, Clinic. Ops, Care Srvce | A Award deriv | 2021-02-10 | 2021-02-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| McAnaney Adam | General Counsel and Secretar | A Award deriv | 2021-02-10 | 2021-02-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Rothman Marc D | Chief Medical Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 50,000 | — | $0 | 50,000 | SEC↗ |